Extract
The comment by C. McCabe and colleagues provides thoughtful insights into the late sequalae of pulmonary embolism. The authors' views and suggestions, based on their clinical experience and expertise, may prove helpful in the ongoing process of reliably (and meaningfully) distinguishing chronic thromboembolic pulmonary hypertension (CTEPH) from chronic thromboembolic disease (CTED) without pulmonary hypertension at rest.
Abstract
From acute to chronic pulmonary embolism http://bit.ly/3893ubd
Footnotes
Conflict of interest: S.V. Konstantinides reports grants and non-financial support from Bayer AG; grants and personal fees from Boehringer Ingelheim, Actelion, Daiichi-Sankyo, Biocompatibles Group UK and MSD, personal fees from Bayer AG and Pfizer-Bristol-Myers Squibb, all outside the submitted work.
Support statement: The work of Stavros Konstantinides was supported by the German Federal Ministry of Education and Research (BMBF 01EO1003). The author is responsible for the contents of this publication.
- Received February 3, 2020.
- Accepted February 3, 2020.
- Copyright ©ERS 2020